Inventor · disambiguated record
Michael Howard Block
Also filed as: BLOCK MICHAEL H · BLOCK MICHAEL HOWARD
14 granted patents·10 pending applications·141 citations·filing 1992–2010
91Inventor score
Top patents by PatentIndex Score
24 records- 0196US7524957B2Compounds effecting glucokinaseASTRAZENECA AB·Filed 2008·Granted Apr 28, 2009·31 cites·22 claims
- 0290US7390908B2Compounds effecting glucokinaseASTRAZENECA AB·Filed 2002·Granted Jun 24, 2008·33 cites·19 claims
- 0375US6878712B1Amides as inhibitors for pyruvate dehydrogenaseASTRAZENECA AB·Filed 2000·Granted Apr 12, 2005·8 cites·13 claims
- 0473US7951830B2Compounds effecting glucokinaseASTRAZENECA AB·Filed 2009·Granted May 31, 2011·1 cites·11 claims
- 0572US6552225B1Chemical compoundsASTRAZENECA AB·Filed 2000·Granted Apr 22, 2003·7 cites·13 claims
- 0670US5300509A2-furyl-oxazolo[5,4-d]-pyrimidinesICI PLC·Filed 1992·Granted Apr 5, 1994·24 cites·8 claims
- 0768US5500428AFuryl-substituted purines and adenosine antagonistsICI PLC·Filed 1994·Granted Mar 19, 1996·22 cites·9 claims
- 0865US6689909B1Substituted N-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activityASTRAZENECA AB·Filed 2000·Granted Feb 10, 2004·3 cites·13 claims
- 0957US6498275B1Use of compounds for the elevation of pyruvate dehydrogenase activityASTRAZENECA AB·Filed 1999·Granted Dec 24, 2002·12 cites·9 claims
- 1055US2009099210A1Enantiomers of selected fused heterocyclics and uses thereofASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1154US2008153854A1Novel fused heterocycles and uses thereofASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1253US2007142413A1Pyrazole derivatives as inhibitors of receptor tyrosone kinasesBLOCK MICHAEL H·Filed 2004·Application pending·0 cites
- 1351US7498333B2Enantiomers of selected fused heterocyclics and uses thereofASTRAZENECA AB·Filed 2005·Granted Mar 3, 2009·0 cites·4 claims
- 1451US7332492B2Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by NP Y5 receptorASTRAZENECA AB·Filed 2005·Granted Feb 19, 2008·0 cites·12 claims
- 1549US6960688B2Use of compounds for the elevation of pyruvate dehydrogenase activityASTRAZENECA AB·Filed 2002·Granted Nov 1, 2005·0 cites·11 claims
- 1646US7408064B2Carbazole derivatives and their use as NPY5 receptor antagonistsASTRAZENECA AB·Filed 2002·Granted Aug 5, 2008·0 cites·2 claims
- 1745US6967216B2Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by NP Y5 receptorASTRAZENECA AB·Filed 2001·Granted Nov 22, 2005·0 cites·19 claims
- 1845US2006063751A1Novel fused heterocycles and uses thereofASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 1945US2008293744A1Enantiomers of Selected Fused Pyrimidones and Uses in the Treatment and Prevention of CancerASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 2042US2010152219A1Pyrazole derivatives as inhibitors of receptor tyrosine kinasesASTRAZENECA R & D·Filed 2010·Application pending·0 cites
- 2138US2004067999A1Carbazole derivatives and their use as neuropeptide y5 receptor ligandsFiled 2001·Application pending·0 cites
- 2238US2007287703A1Fused Pyrimidones Useful in the Treatment and the Prevention of CancerASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 2338US2006041128A1Selected fused heterocyclics and uses thereofASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 2435US2007249636A1Selected Fused Heterocyclics and Uses ThereofASTRAZENECA AB·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Howard Block files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →